Free Trial
NYSEAMERICAN:CRHM

CRH Medical (CRHM) Stock Price, News & Analysis

CRH Medical logo
$3.99 0.00 (0.00%)
(As of 04/22/2021)

About CRH Medical Stock (NYSEAMERICAN:CRHM)

Key Stats

Today's Range
$3.99
$4.00
50-Day Range
N/A
52-Week Range
$1.66
$4.01
Volume
388,400 shs
Average Volume
1.04 million shs
Market Capitalization
$285.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 70 ambulatory surgical/endoscopy centers in 14 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.

Receive CRHM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CRH Medical and its competitors with MarketBeat's FREE daily newsletter.

CRHM Stock News Headlines

CRH plc (CRH) Q2 2024 Earnings Call Transcript
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
CRH PLC American Depositary Shares (CRH)
CRH Medical Corp (CRHM)
See More Headlines

CRHM Stock Analysis - Frequently Asked Questions

CRH Medical Co. (NYSEAMERICAN:CRHM) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.01) EPS for the quarter, meeting analysts' consensus estimates of ($0.01). The company earned $30.35 million during the quarter, compared to the consensus estimate of $29.50 million. CRH Medical had a negative trailing twelve-month return on equity of 3.37% and a negative net margin of 4.12%.

Shares of CRHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that CRH Medical investors own include CRH Medical (CRH), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), AcelRx Pharmaceuticals (ACRX), Ampio Pharmaceuticals (AMPE), Extreme Networks (EXTR) and Palatin Technologies (PTN).

Company Calendar

Last Earnings
11/12/2020
Today
11/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Services
Sub-Industry
Healthcare
Current Symbol
NYSEAMERICAN:CRHM
Previous Symbol
NYSEARCA:CRHM
CIK
N/A
Fax
N/A
Employees
133
Year Founded
N/A

Profitability

Net Income
$3.77 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$120.39 million
Cash Flow
$0.99 per share
Book Value
$1.73 per share

Miscellaneous

Free Float
N/A
Market Cap
$285.76 million
Optionable
Not Optionable
Beta
2.41
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSEAMERICAN:CRHM) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners